WISCONSIN STATE LABORATORY OF HYGIENE 1 State Lab Perspective Julie Tans-Kersten, MS, BS-MT (ASCP) Tuberculosis Laboratory Program Coordinator Wisconsin.

Slides:



Advertisements
Similar presentations
DOTS/ DOTS PLUS IMPLEMENTATION AND INTEGRATION Vaira Leimane State Centre of Tuberculosis and Lung Diseases of Latvia Paris, October, 28.
Advertisements

Ruqaya Mustafa Ali Genetic Engineering and Biotechnology.
Dr R Ramachandran 5 th Joint International Monitoring Mission to Review NTP Thailand 5th JMM Thailand.
Endemic or Outbreak? Differentiating recent transmission of an historic tuberculosis strain in New York City IUATLD-NAR 16 th Annual Meeting February 23-25,
Your Laboratory Ebola Plan Peter Shult, Ph.D. - Director Communicable Disease Division and Emergency Laboratory Response, WSLH, Madison, WI,
Mortality Among a Tuberculosis Outbreak Los Angeles County, 2007–2013 Brian Baker, MD Amit Chitnis, MD MPH Leslie Henry, BSN RN PHN 48th CTCA Educational.
MDCH STATE LABORATORY TUBERCULOSIS TESTING Specimens/Tests/Reports
Nucleic Acid Amplification Test for Tuberculosis
Case discussion Michael Gardam University Health Network.
MTB OUTBREAK LOCAL LAB RESPONSE Chris Partington MT(ASCP) ACL MICROBIOLOGY LAB.
Sheboygan County 2013 Sandy Muesegades, RN – Public Health Nurse.
Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and Rifampin Resistance in HIV Infected & HIV uninfected Pulmonary TB suspects: ACTG.
REALM project update MRSA and KPC January 26, 2011 Michael Lin, MD MPH on behalf of REALM co-investigators.
EPIDEMIOLOGY AND SURVEILLANCE Southwest Florida Disaster Healthcare Coalition June 13, 2014 Jennifer Roth, MSPH Director of Epidemiology Florida Department.
TB Outbreak in Grand Forks
Module 3: Drug-Resistant TB. Learning Objectives Describe how drug resistance emerges Explain the difference between primary and secondary resistance.
Melinda E. Clark, Ph.D. Division of Consolidated Laboratory Services
ISDH Lab TB Testing Update Lixia Liu PhD MP(ASCP) September 16, 2010.
West Virginia Office of Laboratory Services Nicole Haddox, B.S. Microbiology- Tuberculosis Unit 1.
COUNTRY XEPERIENCE AND RESPONSE TO MDR AND XDR TUBERCULOSIS PRESENTED AT THE WHO TB/HIV PLANNING MEETING, ADDIS ABBABA, 11-12, NOVEMBER 2008 BY MS GUGU.
Epidemiology of Multidrug-Resistant TB in Wisconsin Philip Wegner TB Nurse Consultant October 15, 2013.
2014 WI TB Update WI TB Program Wisconsin Department of Health Services Pa Vang, RN, MSN WI TB Program TB Summit, 2014 WI TB Program Update.
MAC PCR at WSLH Julie Tans-Kersten, MS, BS-MT (ASCP)
Molecular methods for TB drug resistance testing: what is needed? Experience from Khayelitsha, Cape Town, South Africa Helen Cox, PhD, Burnet Institute.
Characteristics and Outcomes of a Population of Tuberculosis Inpatients in Lilongwe, Malawi Mina Hosseinipour, MD, MPH Clinical Director UNC Project Lilongwe,
Module 4: From Suspect to Confirmed Case. Learning Objectives Explain why sputum microscopy is important Describe the process for confirming a TB suspect.
Tuberculosis Transmission Knows No Borders: Genotype Clusters Along Texas- Mexico Border Nicole Evert, MS Genotyping Coordinator Texas Department of State.
PRE-EXTENSIVELY DRUG RESISTANT (XDR) TB IN WISCONSIN  Marathon County  Population 134,700  1,545 square miles  Marathon County Health Department 
Comparison of Molecular and Conventional Methods for Detection of Multidrug-Resistant Tuberculosis in the United States, 2009 to 2011 Mitchell A. Yakrus,
Colorado Department of Public Health and Environment Tuberculosis Prevention and Control Program.
Presented by: Kim Chandler
1 INFLUENZA (AND OTHER RESPIRATORY VIRUS) SURVEILLANCE IN WISCONSIN Thomas Haupt M.S. Wisconsin Influenza Surveillance Coordinator.
WISCONSIN STATE LABORATORY OF HYGIENE 1 WSLH: Laboratory Update Tuberculosis Summit Verona, WI April 24, 2014 Julie Tans-Kersten, MS, BS-MT (ASCP) Tuberculosis.
CLINICAL DIAGNOSTIC TB LABORATORY Alexander Sloutsky, Director University of Massachusetts Supranational Reference TB Laboratory Boston, MA.
Association of Public Health Laboratories (APHL) Laboratory System Improvement Program (L-SIP) Jill Power New Hampshire Public Health Laboratories Presented.
Treatment of Tuberculosis: New Case Case Studies Module 7A2 – March 2010.
Wisconsin State Laboratory of Hygiene. WISCONSIN STATE LABORATORY OF HYGIENE Case Study Youngmi Kim, MS, ASCP(M) Senior Microbiologist, Wisconsin State.
Progress of the Singapore TB Elimination Programme (STEP)
Dr. Hind E. Satti Partners In Health, Lesotho March, 2008.
Introduction to Tuberculosis Genotyping National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Tuberculosis Elimination.
Texas Influenza Surveillance Lesley Bullion Influenza Surveillance Coordinator Infectious Disease Control Unit.
Division of Public Health CRE Surveillance and Prevention of Transmission in Healthcare Settings Gwen Borlaug, CIC, MPH Coordinator, Healthcare-Associated.
I AM NOT HOMELESS CSTE JUNE 2013 Dee Pritschet, TB Controller – North Dakota Department of Health Shawn McBride, Epidemiologist – North Dakota Department.
Revision of new diagnostics for TB
Infection Control in Tanzania Dr. Peter C. Mgosha (MPH,) MINISTRY OF HEALTH AND SOCIAL WELFARE NATIONAL AIDS COTROL PROGRAMME P.O.BOX DAR Es SALAAM.
NAAT Is it Time for a New Option in California?. Background CDC 2009 guidelines recommend NAAT for each patient with suspected TB for whom the test result.
Test 1Test 2Test 3Test 4Test 5Test 6 Sensitivity Specificity PPV NPV Performance.
By: Mpho Kontle and Topo Moses. Introduction & Etiology Multi-drug-resistant tuberculosis (MDR-TB) is defined as tuberculosis that is resistant to at.
TB Prevention and Control in Correctional and Detention Facilities Mark Lobato, MD Division of TB Elimination Centers for Disease Control and Prevention.
Correlation of National Influenza Surveillance Data to the Local Experience Kate Goodin, MPH Florida Department of Health Bureau of Epidemiology 6 th Annual.
REMoxTB – a microbiological challenge Dr Anna Bateson Dr. Tim McHugh, Robert Hunt, Emma Cunningham (Emily Bongard, Holly Ciesielczuk)
PMDT IN CHINESE TAIPEI ECONOMY Anita Pei-Chun Chan, MD, PhD Medical Officer, TCDC Associated Director, TB Research Center, TCDC Assistant Professor, Institute.
INSTITUTO DE INFECTOLOGIA EMÍLIO RIBAS Identification of Mycobacterium tuberculosis complex in clinical specimens of HIV-infected patients at Instituto.
National Tuberculosis Genotyping Service
TB Genotyping and Whole Genome Sequencing in California
Whole-Genome Sequencing; It’s Not Just For Epis
Fifth Pacific Stop TB meeting Fiji Islands, May 4-7, 2010
This is an archived document.
Nucleic Acid Amplification Test for Tuberculosis
Vibrio parahaemolyticus in Virginia
Laboratory Testing for Tuberculosis
Laboratory ‘Network’ Update New York State Department of Health
2017 World TB Day Jessica Gentry Tuberculosis Laboratory Supervisor
“Bug of the month “ Pseudomonas aeruginosa (Gram negative bacilli)
Deciphering TB Lab Reports
Using Whole Genome Sequencing Analysis in California
Tuberculosis Control Program
Perspectives from Los Angeles County Tuberculosis Control Program
Laura Lane, Epidemiologist
Jessica Gentry Tuberculosis Laboratory Supervisor
Presentation transcript:

WISCONSIN STATE LABORATORY OF HYGIENE 1 State Lab Perspective Julie Tans-Kersten, MS, BS-MT (ASCP) Tuberculosis Laboratory Program Coordinator Wisconsin State Laboratory of Hygiene (608)

WISCONSIN STATE LABORATORY OF HYGIENE Testing Timeline, Index Patient 4/12/13 (Saturday): sputum specimens collected 4/15/13: smear result: 4+ positive 4/15/13: TB PCR positive 4/15/13: sent sediment for MDDR testing –California Public Health Laboratory: pyrosequencing for detection of mutations that confer INH and rifampin resistance 4/23/13: Culture confirmation of MTBC 2

WISCONSIN STATE LABORATORY OF HYGIENE Initial Molecular Results 3

WISCONSIN STATE LABORATORY OF HYGIENE Testing Timeline 4/12/13: WSLH received specimens from index case ACL started receiving specimens from contacts about 1 week later Specimens from index case collected by the public health department (to WSLH) Specimens from contacts collected at community hospital (to ACL) 4

WISCONSIN STATE LABORATORY OF HYGIENE Discordant Molecular Results: CA (pyrosequencing) 5

WISCONSIN STATE LABORATORY OF HYGIENE Discordant Molecular Results: CDC (Sanger Sequencing) 6

WISCONSIN STATE LABORATORY OF HYGIENE Testing Timeline Learned of drug resistance and possible outbreak at about the same time 4/29/13: started receiving bloody specimens from ACL for TB PCR 5/7/13: 7 contacts with active TB, most specimens had been going to ACL 5/8/13: ACL begins forwarding specimens to WSLH 5/10/13: community hospital starts sending specimens directly to WSLH 7

WISCONSIN STATE LABORATORY OF HYGIENE Significance of discordant Results Sequencing of KatG locus gave “clean” results Sequencing of rpoB locus gave “heterogenous” results Genotyping for index patient was “heterogenous” Genotype results between index case and contacts did not match. 8

WISCONSIN STATE LABORATORY OF HYGIENE Discordant Results Discovery that the index patient is infected with two strains of TB: –INH-resistant Beijing strain –INH and rifampin resistant Manila strain 9

WISCONSIN STATE LABORATORY OF HYGIENE Significance of discordant Results Sequencing of KatG locus gave “clean” results Sequencing of rpoB locus gave “heterogenous” results Genotyping for index patient was “heterogenous” Genotype results between index case and contacts did not match. 10

WISCONSIN STATE LABORATORY OF HYGIENE 11

WISCONSIN STATE LABORATORY OF HYGIENE WSLH Testing Volume (Specimens per week), n=113 12

WISCONSIN STATE LABORATORY OF HYGIENE 13 Sheboygan Public Health Dept Sheboygan Memorial Hospital Marathon County Public Health Dept ACL: smear, culture, MTD WSLH: smear, culture, TB PCR, conventional DST CDC: MDDR and Conventional second-line DST MI Public Health Lab: Genotyping CA Public Health Lab: MDDR and conventional DST Submitters and Health Care Providers Local Public Health Departments State TB Program CDC

WISCONSIN STATE LABORATORY OF HYGIENE Lessons Learned It is difficult to keep track of TB suspects, test results and test volumes when specimens are submitted to multiple labs Discordant results can cause confusion and delay appropriate patient management Data management is critical (everyone has a spreadsheet). Routine conference calls were invaluable This outbreak highlights partnerships between local laboratories, WSLH, Local Public Health Departments, WI State Division of Public Health and CDC. 14

WISCONSIN STATE LABORATORY OF HYGIENE Thank You Wisconsin TB Program Sheboygan public health Department Marathon County Public Health Department ACL Laboratories St. Vincent Lab, Green Bay (800 QFTs) 15

WISCONSIN STATE LABORATORY OF HYGIENE Contact Information Julie Tans-Kersten Tuberculosis Laboratory Program Coordinator Wisconsin State Lab of Hygiene (608) Fax: (608) TB (Mycobacteriology) Lab: (608)

WISCONSIN STATE LABORATORY OF HYGIENE 17 Dave Julie TK Julie B. Nate Youngmi and Ana WSLH Laboratory Team Don